Common use of GENTA Clause in Contracts

GENTA. JAGO undertakes to conduct the development of the Prototype Formulation(s) and the Final Product in an efficient and professional manner. KRYPTON shall actively support GENTA JAGO regarding the development and studies to be executed by GENTA JAGO as may be reasonably required by GENTA JAGO from time to time. In particular, KRYPTON shall provide information reasonably requested by GENTA JAGO relating to the Originator and to the Active Ingredient for the purposes of carrying out this development, including, but not limited to, physico-chemical characteristics, safe-handling instructions, in-vitro analytical methods, degradation products and standards and analytical methods therefore. Additionally, KRYPTON shall provide to GENTA JAGO requested data and adequate quantities of samples of the Originator for the purposes of conducting the Feasibility Study. KRYPTON, however, shall not be required to provide information regarding the Originator which is not in the public domain, unless KRYPTON is duly authorized to possess and disclose such non-public information. Any costs and expenses incurred by KRYPTON in connection with such support shall be borne by KRYPTON.

Appears in 4 contracts

Samples: Sub License Agreement (Genta Incorporated /De/), Sub License Agreement (Genta Incorporated /De/), Sub License Agreement (Genta Incorporated /De/)

AutoNDA by SimpleDocs

GENTA. JAGO undertakes to conduct the development of the Prototype Formulation(s) and the Final Product in an efficient and professional manner. KRYPTON shall actively support GENTA JAGO regarding the development and studies to be executed by GENTA JAGO as may be reasonably required by GENTA JAGO from time to time. In particular, KRYPTON shall provide information reasonably requested by GENTA JAGO relating to the Originator and to the Active Ingredient for the purposes of carrying out this development, including, but not limited to, physico-chemical characteristics, safe-safe- handling instructions, in-vitro analytical methods, degradation products and standards and analytical methods therefore. Additionally, KRYPTON shall provide to GENTA JAGO requested data and adequate quantities of samples of the Originator for the purposes of conducting the Feasibility Study. KRYPTON, however, shall not be required to provide information regarding the Originator which is not in the public domain, unless KRYPTON is duly authorized to possess and disclose such non-public information. Any costs and expenses incurred by KRYPTON in connection with such support shall be borne by KRYPTON.

Appears in 1 contract

Samples: Sub License Agreement Diclofenac (Genta Incorporated /De/)

AutoNDA by SimpleDocs
Time is Money Join Law Insider Premium to draft better contracts faster.